Clinical Trial Update: Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of induction regimens using tacrolimus and mycophenolate mofetil with rapid withdrawal of steroids in kidney transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• PREDNISONE (Prednisone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-07-08